In AMI patients, exosome miR-186-5p is highly expressed, which not only has high diagnostic value, but also inhibits macrophage atherosclerosis by regulating the downstream molecule LOX-1, which can be used as a biomarker to assess atherosclerosis. The gene discussed is OLR1; the disease is atherosclerosis.